These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 33114154)

  • 1. Role of Oxidative Stress and Neuroinflammation in Attention-Deficit/Hyperactivity Disorder.
    Corona JC
    Antioxidants (Basel); 2020 Oct; 9(11):. PubMed ID: 33114154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Potential Role for Neuroinflammation in ADHD.
    Vázquez-González D; Carreón-Trujillo S; Alvarez-Arellano L; Abarca-Merlin DM; Domínguez-López P; Salazar-García M; Corona JC
    Adv Exp Med Biol; 2023; 1411():327-356. PubMed ID: 36949317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidants as a Potential Target against Inflammation and Oxidative Stress in Attention-Deficit/Hyperactivity Disorder.
    Alvarez-Arellano L; González-García N; Salazar-García M; Corona JC
    Antioxidants (Basel); 2020 Feb; 9(2):. PubMed ID: 32098021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammation as a risk factor for attention deficit hyperactivity disorder.
    Dunn GA; Nigg JT; Sullivan EL
    Pharmacol Biochem Behav; 2019 Jul; 182():22-34. PubMed ID: 31103523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent research on the role of oxidative stress in the pathogenesis of attention deficit hyperactivity disorder].
    Wu CL; Wang MF; Zhou RY
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Feb; 26(2):201-206. PubMed ID: 38436320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D's Molecular Action Mechanism in Attention-Deficit/ Hyperactivity Disorder: A Review of Evidence.
    Saedisomeolia A; Samadi M; Gholami F; Seyedi M; Effatpanah M; Hashemi R; Abdolahi M; Honarvar NM
    CNS Neurol Disord Drug Targets; 2018; 17(4):280-290. PubMed ID: 29714151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review on the Role of Inflammation in Attention-Deficit/Hyperactivity Disorder.
    Leffa DT; Torres ILS; Rohde LA
    Neuroimmunomodulation; 2018; 25(5-6):328-333. PubMed ID: 29874674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroinflammation as a possible link between attention-deficit/hyperactivity disorder (ADHD) and pain.
    Kerekes N; Sanchéz-Pérez AM; Landry M
    Med Hypotheses; 2021 Dec; 157():110717. PubMed ID: 34717072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell-mediated neuroinflammation may have a role in attention deficit hyperactivity disorder (Review).
    Song Y; Lu M; Yuan H; Chen T; Han X
    Exp Ther Med; 2020 Aug; 20(2):714-726. PubMed ID: 32742317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Compounds for the Management of Parkinson's Disease and Attention-Deficit/Hyperactivity Disorder.
    Corona JC
    Biomed Res Int; 2018; 2018():4067597. PubMed ID: 30596091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for Dietary Antioxidant Treatment of ADHD.
    Verlaet AAJ; Maasakkers CM; Hermans N; Savelkoul HFJ
    Nutrients; 2018 Mar; 10(4):. PubMed ID: 29587355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative and nitrosative stress in ADHD: possible causes and the potential of antioxidant-targeted therapies.
    Lopresti AL
    Atten Defic Hyperact Disord; 2015 Dec; 7(4):237-47. PubMed ID: 25894292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of total oxidative status in adult attention deficit hyperactivity disorder and its diagnostic implications.
    Selek S; Bulut M; Ocak AR; Kalenderoğlu A; Savaş HA
    J Psychiatr Res; 2012 Apr; 46(4):451-5. PubMed ID: 22257388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
    Villemonteix T; Purper-Ouakil D; Romo L
    Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interactions among organophosphate pesticide exposure, oxidative stress, and genetic polymorphisms of dopamine receptor D4 increase the risk of attention deficit/hyperactivity disorder in children.
    Chang CH; Yu CJ; Du JC; Chiou HC; Chen HC; Yang W; Chung MY; Chen YS; Hwang B; Mao IF; Chen ML
    Environ Res; 2018 Jan; 160():339-346. PubMed ID: 29054088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention-deficit/hyperactivity disorder: a selective overview.
    Biederman J
    Biol Psychiatry; 2005 Jun; 57(11):1215-20. PubMed ID: 15949990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Neuroinflammation with Abscisic Acid Reduces Pain Sensitivity in Females and Hyperactivity in Males of an ADHD Mice Model.
    Meseguer-Beltrán M; Sánchez-Sarasúa S; Landry M; Kerekes N; Sánchez-Pérez AM
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered hypothalamus-pituitary-adrenal axis function: A relevant factor in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder?
    Buske-Kirschbaum A; Trikojat K; Tesch F; Schmitt J; Roessner V; Luksch H; Rösen-Wolff A; Plessow F
    Psychoneuroendocrinology; 2019 Jul; 105():178-186. PubMed ID: 30583940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder.
    Sergeant J
    Neurosci Biobehav Rev; 2000 Jan; 24(1):7-12. PubMed ID: 10654654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared Brain Connectivity Issues, Symptoms, and Comorbidities in Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder, and Tourette Syndrome.
    Kern JK; Geier DA; King PG; Sykes LK; Mehta JA; Geier MR
    Brain Connect; 2015 Aug; 5(6):321-35. PubMed ID: 25602622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.